AU568312B2 - Antibiotic 1-(substituted hydroxy)-2-azetidinones - Google Patents

Antibiotic 1-(substituted hydroxy)-2-azetidinones

Info

Publication number
AU568312B2
AU568312B2 AU19939/83A AU1993983A AU568312B2 AU 568312 B2 AU568312 B2 AU 568312B2 AU 19939/83 A AU19939/83 A AU 19939/83A AU 1993983 A AU1993983 A AU 1993983A AU 568312 B2 AU568312 B2 AU 568312B2
Authority
AU
Australia
Prior art keywords
azetidinones
antibiotic
substituted hydroxy
hydroxy
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU19939/83A
Other languages
English (en)
Other versions
AU1993983A (en
Inventor
David Roy Kronenthal
William Allen Slusarchyk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of AU1993983A publication Critical patent/AU1993983A/en
Application granted granted Critical
Publication of AU568312B2 publication Critical patent/AU568312B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU19939/83A 1982-10-06 1983-10-06 Antibiotic 1-(substituted hydroxy)-2-azetidinones Ceased AU568312B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43317582A 1982-10-06 1982-10-06
US433175 1982-10-06

Publications (2)

Publication Number Publication Date
AU1993983A AU1993983A (en) 1984-04-12
AU568312B2 true AU568312B2 (en) 1987-12-24

Family

ID=23719123

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19939/83A Ceased AU568312B2 (en) 1982-10-06 1983-10-06 Antibiotic 1-(substituted hydroxy)-2-azetidinones

Country Status (27)

Country Link
JP (1) JPS5988462A (el)
KR (1) KR900005132B1 (el)
AU (1) AU568312B2 (el)
BE (1) BE897883A (el)
CA (1) CA1253501A (el)
CH (1) CH658858A5 (el)
DD (1) DD222016A5 (el)
DE (1) DE3336262A1 (el)
DK (1) DK457983A (el)
ES (1) ES8504814A1 (el)
FI (1) FI833631A (el)
FR (1) FR2534253B1 (el)
GB (1) GB2129428B (el)
GR (1) GR79704B (el)
HU (1) HU190507B (el)
IE (1) IE56600B1 (el)
IL (1) IL69917A (el)
IT (1) IT1171722B (el)
LU (1) LU85033A1 (el)
NL (1) NL8303410A (el)
NO (1) NO833626L (el)
NZ (1) NZ205642A (el)
PH (1) PH24175A (el)
PT (1) PT77458B (el)
SE (1) SE8305509L (el)
SU (1) SU1318146A3 (el)
ZA (1) ZA837491B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004876A1 (en) * 1984-04-24 1985-11-07 Takeda Chemical Industries, Ltd. 2-azetidinone derivatives and process for their preparation
EP0135194A1 (en) * 1983-09-16 1985-03-27 Takeda Chemical Industries, Ltd. Azetidinones and their production
US4581170A (en) * 1984-08-03 1986-04-08 E. R. Squibb & Sons, Inc. N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
EP0171064B1 (en) * 1984-08-06 1995-07-12 Fujisawa Pharmaceutical Co., Ltd. Azetidinone derivative and processes for production thereof
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates

Also Published As

Publication number Publication date
SU1318146A3 (ru) 1987-06-15
IE56600B1 (en) 1991-10-09
JPS5988462A (ja) 1984-05-22
NO833626L (no) 1984-04-09
GR79704B (el) 1984-10-31
SE8305509L (sv) 1984-04-07
PH24175A (en) 1990-03-22
ZA837491B (en) 1984-06-27
GB2129428B (en) 1986-03-19
DK457983A (da) 1984-04-07
DK457983D0 (da) 1983-10-04
IL69917A (en) 1987-10-20
DD222016A5 (de) 1985-05-08
PT77458B (en) 1986-02-26
FI833631A0 (fi) 1983-10-06
CA1253501A (en) 1989-05-02
DE3336262A1 (de) 1984-04-12
IE832354L (en) 1984-04-06
CH658858A5 (fr) 1986-12-15
AU1993983A (en) 1984-04-12
BE897883A (fr) 1984-03-30
FR2534253A1 (fr) 1984-04-13
FR2534253B1 (fr) 1985-07-26
KR900005132B1 (ko) 1990-07-20
KR840006337A (ko) 1984-11-29
HU190507B (en) 1986-09-29
ES526282A0 (es) 1985-04-16
IT1171722B (it) 1987-06-10
IT8323172A0 (it) 1983-10-06
PT77458A (en) 1983-11-01
FI833631A (fi) 1984-04-07
GB2129428A (en) 1984-05-16
NL8303410A (nl) 1984-05-01
IL69917A0 (en) 1984-01-31
NZ205642A (en) 1986-08-08
ES8504814A1 (es) 1985-04-16
LU85033A1 (fr) 1984-05-10
SE8305509D0 (sv) 1983-10-06
GB8326626D0 (en) 1983-11-09

Similar Documents

Publication Publication Date Title
AU557191B2 (en) Window
AU2193783A (en) Substituted tetrpeptides
AU568062B2 (en) B-lactam antibiotic
AU567294B2 (en) Carbapenem antibiotics
AU570271B2 (en) Bbm-2478 antibiotic complex
AU567695B2 (en) Aminoglycoside derivatives
AU572090B2 (en) Carbapenem antibiotics
AU575541B2 (en) 2-heteraralkyl-thio carbapenem antibiotics
AU566627B2 (en) Herbicidal antibiotic
AU553011B2 (en) Buffer
AU2216483A (en) Anthracylinone antibiotics
AU1112183A (en) Substituted thienobenzodiazepinones
AU568312B2 (en) Antibiotic 1-(substituted hydroxy)-2-azetidinones
AU567112B2 (en) Substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols
AU586037B2 (en) Substituted ethanediimidamides
AU585264B2 (en) Antibiotic A80190
AU536957B2 (en) Antibiotic am-3603
AU7860281A (en) Antibiotic a-4696 factor g
AU542257B2 (en) Antibiotic pa-39504-x3
AU563089B2 (en) Door stop
AU1983583A (en) Aminoglycoside derivatives
AU1379483A (en) Anordning for vavnadsprovtagning
AU544407B2 (en) Novel antibiotic 5057b
AU536565B2 (en) Aminoglycoside antibiotics
AU537240B2 (en) Aminoglycoside antibiotics